Apellis Pharmaceuticals: A Mixed Bag

Live Chat on The Biotech Forum has been dominated by discussion of these type of buy-write opportunities over the past several trading sessions. To see what I and the other season biotech investors are targeting as trading ideas real-time, just initiate your two-week no obligation free trial into The Biotech Forum by clicking HERE .Today, we put Apellis Pharmaceuticals, Inc. (NASDAQ: APLS ) in the spotlight. As can be seen below, the stock of this commercial stage mid-cap biopharma has been consistently gri ...